• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CG Oncology, Inc. - Common stock (NQ:CGON)

    69.53 +0.00 (+0.01%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 236
    Open 69.53
    Bid (Size) 67.41 (100)
    Ask (Size) 69.54 (100)
    Prev. Close 69.53
    Today's Range 69.53 - 69.53
    52wk Range 23.32 - 75.50
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears ↗
    CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for cretostimogene in BCG-unresponsive high-risk non-muscle invasive bladder... 
    Via MarketBeat
    Topics Initial Public Offering
    News headline image
    CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
    From CG Oncology Inc.
    Via GlobeNewswire

    Performance

    YTD
    +66.4%
    +66.4%
    1 Month
    +3.4%
    +3.4%
    3 Month
    +34.7%
    +34.7%
    6 Month
    +84.1%
    +84.1%
    1 Year
    +187.7%
    +187.7%

    More News

    Read More
    News headline image
    CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings ↗
    Via Benzinga
    CG Oncology Inc (NASDAQ:CGON) Shows Perfect Technical Rating and Strong Setup Quality for Potential Breakout ↗
    Via Chartmill
    News headline image
    CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present at Upcoming Investor Conferences in May
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗
    Via The Motley Fool
    News headline image
    This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ImmunityBio (IBRX) Shares Plummet Despite Piper Sandler Price Target Hike and 700% Revenue Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
    Via MarketMinute
    Topics Intellectual Property
    What's going on in today's session ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CG Oncology Announces New Board Member and Board Transition
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
    From CG Oncology Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is CG Oncology, Inc. - Common stock publicly traded?
    Yes, CG Oncology, Inc. - Common stock is publicly traded.
    What exchange does CG Oncology, Inc. - Common stock trade on?
    CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CG Oncology, Inc. - Common stock?
    The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
    What is the current price of CG Oncology, Inc. - Common stock?
    The current price of CG Oncology, Inc. - Common stock is 69.53
    When was CG Oncology, Inc. - Common stock last traded?
    The last trade of CG Oncology, Inc. - Common stock was at 05/14/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.